SCI Corporation (NYSE American: CVM) announced today that during its annual Shareholder’s Meeting on May 19, 2025, a ...

Clinical stage cancer immunotherapy company CEL-SCI (NYSE:CVM) priced an underwritten public offering of 2M shares at a public offering price of $2.50 per share. Total gross proceeds are expected ...

When the market opens on May 20, 2025, the common stock will trade under a new CUSIP number 150837 706, but the Company's ticker symbol, CVM, will remain unchanged. When the combination of stock ...